Sintx Technologies Inc (SINT)

$2.49 -0.09 (-3.49%)
Market Cap 9.80M
Revenue (ttm) 2.89M
Net Income (ttm) -11.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.31%
Debt to Equity Ratio 0.01
Volume 26,200
Avg Vol 35,468
Day's Range N/A - N/A
Shares Out 3.68M
Stochastic %K 23%
Beta 0.67
Analysts Sell
Price Target $16.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
Boston7452
Boston7452 Mar. 21 at 11:08 PM
$SINT Try to warn people about the possibility of Lexx's intention to Reverse split to cost basis harvest like has been done here (shouldnt be as bad as here) and they attack me for it.
1 · Reply
Makingmillions192
Makingmillions192 Mar. 21 at 8:30 PM
$LEXX I’d be careful with @Boston7452 if you look at his coverage on $SINT and others he’s clearly in the business of shorting stocks. I don’t think his MO is any different here - he’s done a good job at making people think he’s actually invested here. Myself included. Let’s hope he’s one of those last few people that are on the short interest.
1 · Reply
HubAllianceModern
HubAllianceModern Mar. 21 at 6:29 PM
$SINT is on my list, just watching.
0 · Reply
Boston7452
Boston7452 Mar. 21 at 4:48 PM
$SINT This is who I believe their mask/woundcare partner to be. I like how Sintx chose Solventum green for its website styling.
1 · Reply
SnoopyDog
SnoopyDog Mar. 21 at 9:52 AM
$SINT Not relevant, no revenue
1 · Reply
SnoopyDog
SnoopyDog Mar. 21 at 8:23 AM
$SINT with no revenues. Youll see a sharp correction monday
0 · Reply
Boston7452
Boston7452 Mar. 20 at 10:28 PM
$SINT "We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings. In 2025, the United States Patent and Trademark Office (“USPTO”) granted our patent application titled, “Antipathogenic Fibrous Materials.” This patent secures broad protection for our proprietary silicon nitride-based antipathogen platform. Additionally, in 2025, the USPTO issued a Notice of Allowance for our patent application containing method claims covering our antipathogenic fabric technology."
0 · Reply
SnoopyDog
SnoopyDog Mar. 20 at 9:57 PM
$SINT While management has implemented plans intended to mitigate these conditions, we have concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these consolidated financial statements are issued. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
0 · Reply
Boston7452
Boston7452 Mar. 20 at 8:12 PM
$SINT “A respiratory virus is spiking in multiple states right now. You’ve likely never heard of it” Yet another respiratory virus spreading in the US that Sintx Si3N4 could likely ”kill” as its a single stranded RNA virus.
0 · Reply
Boston7452
Boston7452 Mar. 20 at 5:40 PM
$SINT These are the most recent buys but the majority of purchases since last year have been above current price.
0 · Reply
Latest News on SINT
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Mar 19, 2026, 7:30 AM EDT - 2 days ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 4 weeks ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 7 weeks ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 3 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 4 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 6 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 6 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 9 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 11 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 1 year ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 2 years ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 21, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Boston7452
Boston7452 Mar. 21 at 11:08 PM
$SINT Try to warn people about the possibility of Lexx's intention to Reverse split to cost basis harvest like has been done here (shouldnt be as bad as here) and they attack me for it.
1 · Reply
Makingmillions192
Makingmillions192 Mar. 21 at 8:30 PM
$LEXX I’d be careful with @Boston7452 if you look at his coverage on $SINT and others he’s clearly in the business of shorting stocks. I don’t think his MO is any different here - he’s done a good job at making people think he’s actually invested here. Myself included. Let’s hope he’s one of those last few people that are on the short interest.
1 · Reply
HubAllianceModern
HubAllianceModern Mar. 21 at 6:29 PM
$SINT is on my list, just watching.
0 · Reply
Boston7452
Boston7452 Mar. 21 at 4:48 PM
$SINT This is who I believe their mask/woundcare partner to be. I like how Sintx chose Solventum green for its website styling.
1 · Reply
SnoopyDog
SnoopyDog Mar. 21 at 9:52 AM
$SINT Not relevant, no revenue
1 · Reply
SnoopyDog
SnoopyDog Mar. 21 at 8:23 AM
$SINT with no revenues. Youll see a sharp correction monday
0 · Reply
Boston7452
Boston7452 Mar. 20 at 10:28 PM
$SINT "We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings. In 2025, the United States Patent and Trademark Office (“USPTO”) granted our patent application titled, “Antipathogenic Fibrous Materials.” This patent secures broad protection for our proprietary silicon nitride-based antipathogen platform. Additionally, in 2025, the USPTO issued a Notice of Allowance for our patent application containing method claims covering our antipathogenic fabric technology."
0 · Reply
SnoopyDog
SnoopyDog Mar. 20 at 9:57 PM
$SINT While management has implemented plans intended to mitigate these conditions, we have concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these consolidated financial statements are issued. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
0 · Reply
Boston7452
Boston7452 Mar. 20 at 8:12 PM
$SINT “A respiratory virus is spiking in multiple states right now. You’ve likely never heard of it” Yet another respiratory virus spreading in the US that Sintx Si3N4 could likely ”kill” as its a single stranded RNA virus.
0 · Reply
Boston7452
Boston7452 Mar. 20 at 5:40 PM
$SINT These are the most recent buys but the majority of purchases since last year have been above current price.
0 · Reply
Boston7452
Boston7452 Mar. 20 at 3:48 PM
$SINT Mgmt has been buying shares off the open market at higher prices.
0 · Reply
SnoopyDog
SnoopyDog Mar. 20 at 2:49 PM
$SINT the chart looks awful. Also 9 mn MCAP is way to high at the moment considering the offering to come
1 · Reply
FastRocketTraders
FastRocketTraders Mar. 19 at 10:31 PM
$SINT patents?
1 · Reply
Boston7452
Boston7452 Mar. 19 at 5:57 PM
$SINT Think of every point that Sintx next gen biomaterial could be used in the operating room one day. Various Implant not just orthopedic, masks for all medical personnel, air filtration to help maintain OR sterility, antiinfective soaps (maybe but possible), wound dressings and gauze, catheters if used, curtains, scrubs, shoe coverings, even as a coating on tools used for surgery. This list is not exhaustive.
1 · Reply
Boston7452
Boston7452 Mar. 19 at 5:35 PM
$SINT Next Gen biomaterial that actively supports bone integration and healing, reduces post operation infection, and improves imagining during and post implantation.
0 · Reply
SnoopyDog
SnoopyDog Mar. 19 at 1:40 PM
$SINT offering likely coming here at 1.xx
0 · Reply
SnoopyDog
SnoopyDog Mar. 19 at 12:14 PM
$SINT 2.4 to be clear, the news means no revenue for now. One 1 implant
0 · Reply
SnoopyDog
SnoopyDog Mar. 19 at 12:04 PM
$SINT Massacre today
0 · Reply
2TrustHim
2TrustHim Mar. 19 at 11:49 AM
$SINT Finally The Blueprint To Success Being Used!!!
0 · Reply
SnoopyDog
SnoopyDog Mar. 19 at 11:44 AM
$SINT should should If If
0 · Reply
SnoopyDog
SnoopyDog Mar. 19 at 11:43 AM
$SINT with revenue increasing maybe they can cover the salary of one overpayed executive this year
0 · Reply
DARKP00L
DARKP00L Mar. 19 at 11:41 AM
$SINT 07:39 on Mar. 19 2026 SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System #tradeideas
0 · Reply